المؤلفون: Puente, Javier, Anido, Urbano, Angel Climent, Miguel, Gonzalez-Billalabeitia, Enrique, Lainez, Nuria, Lambea, Julio, Pablo Maroto, Jose, Jose Mendez-Vidal, Maria, Montesa, Alvaro, Rodriguez, Angel, Zambrana, Curro, Gonzalez-del-Alba, Aranzazu

المساهمون: Gonzalez-del-Alba, Aranzazu Hosp Univ Puerta Hierro Majadahonda, Med Ongol Dept, Calle Joaquin Rodrigo 2, Madrid 28222, Spain, Puente, Javier Hosp Clin San Carlos, CIBERONC, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Med Oncol Dept, Madrid, Spain, Anido, Urbano Complejo Hosp Univ Santiago, Oncol Dept, Santiago De Compostela, Spain, Angel Climent, Miguel IVO, Med Oncol Dept, Valencia, Spain, Gonzalez-Billalabeitia, Enrique Univ Murcia, IMIB, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, Murcia, Spain, Gonzalez-Billalabeitia, Enrique Univ Catolica San Antonio Murcia UCAM, Murcia, Spain, Lainez, Nuria Complejo Hosp Navarra, Med Oncol Dept, Pamplona, Spain, Lambea, Julio Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Spain, Pablo Maroto, Jose Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain, Jose Mendez-Vidal, Maria Hosp Univ Reina Sofia, Med Oncol Dept, Cordoba, Spain, Montesa, Alvaro Hosp Reg Malaga, Med Oncol Dept, Malaga, Spain, Rodriguez, Angel Hosp Leon, Med Oncol Dept, Leon, Spain, Zambrana, Curro Hosp Univ Infanta Sofia, Med Oncol Dept, San Sebastian De Reyes, Spain, Sanofi

مصطلحات موضوعية: abiraterone acetate, androgen-deprivation therapy, chemotherapy, enzalutamide, metastatic castration-resistant prostate cancer, radium-223, Androgen deprivation therapy, Increased survival, Docetaxel, Men, Cabazitaxel, 1st-line, Upfront

العلاقة: http://hdl.handle.net/10668/19103Test; https://doi.org/10.1177/1758835920920067Test; 538873800001

الإتاحة: https://doi.org/10.1177/1758835920920067Test
http://hdl.handle.net/10668/19103Test

المؤلفون: Beyer, Jörg, Collette, Laurence, Sauvé, Nicolas, Daugaard, Gedske, Feldman, Darren R, Tandstad, Torgrim, Tryakin, Alexey, Stahl, Olof, Gonzalez-Billalabeitia, Enrique, De Giorgi, Ugo, Culine, Stéphane, de Wit, Ronald, Hansen, Aaron R, Bebek, Marko, Terbuch, Angelika, Albany, Costantine, Hentrich, Marcus, Gietema, Jourik A, Negaard, Helene, Huddart, Robert A, Lorch, Anja, Cafferty, Fay H, Heng, Daniel Y C, Sweeney, Christopher J, Winquist, Eric, Chovanec, Michal, Fankhauser, Christian, Stark, Daniel, Grimison, Peter, Necchi, Andrea, Tran, Ben, Heidenreich, Axel, Shamash, Jonathan, Sternberg, Cora N, Vaughn, David J, Duran, Ignacio, Bokemeyer, Carsten, Patrikidou, Anna, Cathomas, Richard, Assele, Samson, Gillessen, Silke

المصدر: International Germ Cell Cancer Classification Update Consortium , Beyer , J , Collette , L , Sauvé , N , Daugaard , G , Feldman , D R , Tandstad , T , Tryakin , A , Stahl , O , Gonzalez-Billalabeitia , E , De Giorgi , U , Culine , S , de Wit , R , Hansen , A R , Bebek , M , Terbuch , A , Albany , C , Hentrich , M , Gietema , J A , Negaard , H , Huddart , R A , Lorch , A , Cafferty ....

مصطلحات موضوعية: GERM-CELL CANCER, CHEMOTHERAPY, CISPLATIN

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/f97de47b-b9d9-457d-92b5-fd00bec662c0Test

الإتاحة: https://doi.org/10.1200/JCO.20.03292Test
https://hdl.handle.net/11370/f97de47b-b9d9-457d-92b5-fd00bec662c0Test
https://research.rug.nl/en/publications/f97de47b-b9d9-457d-92b5-fd00bec662c0Test
https://pure.rug.nl/ws/files/166284118/Survival_and_New_Prognosticators_in_Metastatic_Seminoma_Results_From_the_IGCCCG_Update_Consortium.pdfTest

المؤلفون: García Garre, Elisa, Luengo Gil, Ginés, Montoro García, Silvia, Gonzalez Billalabeitia, Enrique, Zafra Poves, Marta, García Martinez, Elena, Roldán Schilling, Vanessa, Navarro Manzano, Esther, Ivars Rubio, Alejandra, Lip, Gregory Y. H., Ayala de la Peña, Francisco

المصدر: Breast Cancer Research & Treatment; May2018, Vol. 169 Issue 1, p83-92, 10p

المؤلفون: Jiménez, Natalia, Reig, Òscar, Marín-Aguilera, Mercedes, Aversa, Caterina, Ferrer-Mileo, Laura, Font, Albert, Rodríguez-Vida, Alejo, Climent, Miguel Ángel, Cros, Sara, Chirivella, Isabel, Doménech, Montserrat, Figols, Mariona, González-Billalabeitia, Enrique, Jiménez Peralta, Daniel, Rodríguez-Carunchio, Leonardo, García-Esteve, Samuel, García de Herreros, Marta, Ribal, Maria J., Prat, Aleix, Mellado, Begoña

مصطلحات موضوعية: Androgen receptor, Chemotherapy, Estrogen receptor, Hormonal therapy, Metastatic prostate cancer, Predictive biomarkers, Tumor suppressor genes

وصف الملف: application/pdf

العلاقة: Jiménez N, Reig Ò, Marín-Aguilera M, Aversa C, Ferrer-Mileo L, Font A, et al. Transcriptional profile associated with clinical outcomes in metastatic hormone-sensitive prostate cancer treated with androgen deprivation and docetaxel. Cancers (Basel). 2022 Sep 29; 14(19): 4757. DOI:10.3390/cancers14194757; http://hdl.handle.net/10230/55438Test; http://dx.doi.org/10.3390/cancers14194757Test

الإتاحة: https://doi.org/10.3390/cancers14194757Test
http://hdl.handle.net/10230/55438Test

المؤلفون: María José Méndez-Vidal, Enrique Gonzalez-Billalabeitia, Nuria Lainez, Urbano Anido, Álvaro Montesa, Miguel Angel Climent, J. P. Maroto, Javier Puente, Ángel Francisco Zazo Rodríguez, Curro Zambrana, Julio Lambea, A. González-del-Alba

المساهمون: [Gonzalez-del-Alba, Aranzazu] Hosp Univ Puerta Hierro Majadahonda, Med Ongol Dept, Calle Joaquin Rodrigo 2, Madrid 28222, Spain, [Puente, Javier] Hosp Clin San Carlos, CIBERONC, Inst Invest Sanitaria Hosp Clin San Carlos IdISSC, Med Oncol Dept, Madrid, Spain, [Anido, Urbano] Complejo Hosp Univ Santiago, Oncol Dept, Santiago De Compostela, Spain, [Angel Climent, Miguel] IVO, Med Oncol Dept, Valencia, Spain, [Gonzalez-Billalabeitia, Enrique] Univ Murcia, IMIB, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, Murcia, Spain, [Gonzalez-Billalabeitia, Enrique] Univ Catolica San Antonio Murcia UCAM, Murcia, Spain, [Lainez, Nuria] Complejo Hosp Navarra, Med Oncol Dept, Pamplona, Spain, [Lambea, Julio] Hosp Clin Univ Lozano Blesa, Med Oncol Dept, Zaragoza, Spain, [Pablo Maroto, Jose] Hosp Santa Creu & Sant Pau, Med Oncol Dept, Barcelona, Spain, [Jose Mendez-Vidal, Maria] Hosp Univ Reina Sofia, Med Oncol Dept, Cordoba, Spain, [Montesa, Alvaro] Hosp Reg Malaga, Med Oncol Dept, Malaga, Spain, [Rodriguez, Angel] Hosp Leon, Med Oncol Dept, Leon, Spain, [Zambrana, Curro] Hosp Univ Infanta Sofia, Med Oncol Dept, San Sebastian De Reyes, Spain, Sanofi

المصدر: Therapeutic Advances in Medical Oncology, Vol 12 (2020)
Zaguán: Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Therapeutic Advances in Medical Oncology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

مصطلحات موضوعية: Oncology, Radium-223, medicine.medical_specialty, radium-223, medicine.medical_treatment, Docetaxel, Androgen deprivation therapy, Castration resistant, chemotherapy, lcsh:RC254-282, 1st-line, Upfront, Increased survival, 03 medical and health sciences, chemistry.chemical_compound, Prostate cancer, 0302 clinical medicine, Internal medicine, medicine, Enzalutamide, 030212 general & internal medicine, Chemotherapy, Cabazitaxel, enzalutamide, business.industry, Abiraterone acetate, Men, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, metastatic castration-resistant prostate cancer, chemistry, 030220 oncology & carcinogenesis, androgen-deprivation therapy, business, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c0c26be19d7be0e8eed0ba68bd453c9Test
https://doaj.org/article/75ff313d187749adb79d84a4a14b63f7Test

المؤلفون: Antonio Fernández, Jose Luis Aguilar, Pablo Cerezuela, A. Saenz, S. Ros, Alberto Carmona-Bayonas, Sara Fernández, Claudia Valverde, Daniel Castellano, Mireia Margeli, David Hervás, Xavier Garcia del Muro, Grupo Germinal, Francisco Ayala de la Peña, Josep Guma, Javier Sastre, Ignacio Duran, Begoña Mellado, Samuel Rivera, Nora Sobrevilla, Alfonso Sanchez-Muñoz, Jose R. Germa-Lluch, Enrique Gonzalez-Billalabeitia, Ray Manneh, Maria Isabel Luengo, Pablo Maroto, Jorge Aparicio

المساهمون: [Gonzalez-Billalabeitia, Enrique] Hosp Univ Morales Meseguer IMIB, Murcia, Spain, [Luengo, Maria I.] Hosp Univ Morales Meseguer IMIB, Murcia, Spain, [Gonzalez-Billalabeitia, Enrique] Univ Catolica San Antonio Murcia UCAM, Murcia, Spain, [Castellano, Daniel] Hosp Univ 12 Octubre, Madrid, Spain, [Manneh, Ray] Hosp Univ 12 Octubre, Madrid, Spain, [Sobrevilla, Nora] Inst Nacl Cancerol, Mexico City, DF, Mexico, [Guma, Josep] URV, Hosp San Joan de Reus, IISSPV, Tarragona, Spain, [Hervas, David] Inst Invest Sanitaria La Fe, Valencia, Spain, [Aparicio, Jorge] Hosp Univ La Fe, Valencia, Spain, [Sanchez-Munoz, Alfonso] Hos Univ Reg & Virgen de la Victoria Malaga, Invest Clin & Traslac Canc, Inst Invest Biomed Malaga IBIMA, Malaga, Spain, [Mellado, Begona] Hosp Clin Barcelona, IDIBAPS, Serv Oncol Med, Barcelona, Spain, [Saenz, Alberto] Hosp Clin Lozano Blesa, Zaragoza, Spain, [Valverde, Claudia] Hosp Univ Vall dHebron, Barcelona, Spain, [Fernandez, Antonio] Complejo Hosp Univ Albacete, Albacete, Spain, [Margeli, Mireia] Hosp Badalona Germans Trias & Pujol, Inst Catala Oncol, Badalona, Spain, [Duran, Ignacio] Hosp Univ Virgen del Rocio, Seville, Spain, [Fernandez, Sara] Hosp Cent Asturias, Oviedo, Spain, [Sastre, Javier] Hosp Clin San Carlos, Madrid, Spain, [Ros, Silverio] Hosp Virgen Arrixaca, Murcia, Spain, [Maroto, Pablo] Hosp Santa Creu & Sant Pau, Barcelona, Spain, [Cerezuela, Pablo] Hosp Santa Lucia, Cartagena, Spain

المصدر: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

مصطلحات موضوعية: Risk, 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Pathology, Prognostic variable, Survival, Adolescent, medicine.medical_treatment, Disease-Free Survival, 03 medical and health sciences, Bleomycin, Young Adult, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Registries, Young adult, Child, Survival rate, Tumors, Aged, Etoposide, Proportional Hazards Models, Chemotherapy, business.industry, Proportional hazards model, Hazard ratio, Venous Thromboembolism, Middle Aged, Neoplasms, Germ Cell and Embryonal, Prognosis, Confidence interval, Cisplatin-based chemotherapy, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, Female, Cisplatin, business, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdaf539679430e46f25ee5ae30f54be3Test
https://hdl.handle.net/10668/10808Test